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Edited by Felix WielandAbstract Inﬂuenza virus matrix protein 1 (M1) has been shown
to play a crucial role in the virus replication, assembly and bud-
ding. We identiﬁed heat shock cognate protein 70 (Hsc70) as a
M1 binding protein by immunoprecipitation and MALDI-TOF
MS. The C terminal domain of M1 interacts with Hsc70. We
found that Hsc70 does not correlate with the transport of M1
to the nucleus, however, it does inhibit the nuclear export of
M1 and NP, thus resulting in the inhibition of viral production.
This is the ﬁrst demonstration that Hsc70 is directly associated
with M1 and therefore is required for viral production.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The genome of the type A inﬂuenza virus in the virion exists
as a viral ribonucleoprotein (vRNP) complex with RNA-
dependent RNA polymerase (RdRp) and nucleocapsid protein
(NP). The transcription of viral RNA takes place in the nu-
cleus. The early gene products, RdRp (PB1, PB2, and PA),
and NP are transported to nucleus where they form vRNPs.
The vRNP is surrounded by matrix protein 1 (M1), which
has multiple functions in the late stages of infection [1]. Newly
synthesized M1 binds to progeny vRNP [2] and suppresses the
protease activity of the RdRp [3]. M1 also promotes the termi-
nation of viral RNA synthesis. The helix 6 (amino acid resi-
dues 91–105) of M1 plays important roles in its nuclear
localization [2], in the inhibition of RNA synthesis and RNA
binding [4] and in the eﬃcient virus production and virion
morphology [5]. M1 also plays an essential role in the export
of vRNP from nucleus [6]. However, M1 does not possessAbbreviations: Hsps, heat shock proteins; vRNP, viral ribonucleopro-
tein; NP, nucleocapsid protein; M1, matrix protein 1; MALDI-TOF
MS, matrix-assisted laser desorption ionization-time of ﬂight mass
spectrometry; Hsc70, heat shock cognate protein 70
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doi:10.1016/j.febslet.2006.09.040nuclear export signal (NES), thus mechanism of M1-mediated
nuclear export of vRNP is still not well understood.
We herein identify heat shock cognate protein 70 (Hsc70), a
constitutive form of Hsp70 family protein, as an host factor(s)
which bind to M1 in infected cells by matrix-assisted laser
desorption ionization-time of ﬂight mass spectrometry (MAL-
DI-TOF MS). Heat shock proteins (Hsps) were induced by
various stimulations, such as heat treatments, chemicals, UV,
and viral infection. One of the functions of Hsps is to maintain
cellular homeostasis. It has thus been reported that Hsps inhi-
bit the replication of a variety of RNA viruses, such as para-
myxoviruses, rhabdoviruses, rotaviruses, retroviruses and
inﬂuenza virus [7]. On the other hand, many kind of viruses
utilize speciﬁc Hsps for their replication. Hsc70 is involved in
Adenovirus [8], papillomavirus [9], and HTLV-1 [10] propaga-
tion. Hsp70 has been reported to be involved in Canine distem-
per virus [11] and measles virus [12] propagation. We found a
direct interaction and colocalization of Hsc70 and M1. The
knockdown of Hsc70 using SiRNA resulted in a inhibition
of vRNP export from the nucleus, thus resulting in a reduction
of virus production.2. Materials and methods
2.1. Viruses, cells, antibodies and SiRNAs
Inﬂuenza virus A/PR/8/34(H1N1) and A/WSN/33(H1N1) were
propagated in 10-day-old embryonated eggs. Puriﬁed virions were ob-
tained as described previously [13]. 293T cells were maintained in
DMEM. Madin-Darby canine kidney (MDCK), Madin-Darby bovine
kidney (MDBK) and HeLa cells were maintained in MEM. The med-
ium was supplemented with 10% FBS. The preparation of anti-M1 and
anti-NP were previously described [14]. Anti-Hsc70 (SPA-815) and
anti-Hsp70 (SPA-810) were purchased from Stressgen (Victoria BC,
Canada). Anti-actin (A-5060) was purchased from Sigma Aldrich.
Human Hsc70-speciﬁc SiRNA (sc-29349) was purchased from Santa
Cruz Biotechnology, Inc. Random SiRNA was purchased from
iGENE Co. Ltd. (Tsukuba, JAPAN). Transfection of SiRNA into cells
was performed according to manufacturer’s instructions.
2.2. Construction of plasmids
For the construction of pPolI-WSN-MD76–103, pPolI-WSN-M [15]
was digested with PstI and HindIII, and then was ligated with linker
5 0-ACGTTCGA-3 0. For the construction of pPolI-WSN-MD102-201,
pPolI-WSN-M was digested with HindIII and NcoI, and ﬁlled with
Klenow fragment, and then was self-ligated. For the construction of
pPolI-WSN-MD203–252, pPolI-WSN-M was partially digested with
NcoI, ﬁlled with Klenow fragment, and then was self-ligated.blished by Elsevier B.V. All rights reserved.
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MDCK (1 · 107 cells) were infected with inﬂuenza virus (MOI = 1)
for 12 h. The cells were lysed with 400 ll of the lysis buﬀer (50 mM
Tris, pH 7.5, 150 mM NaCl, 0.5% TritonX-100, 2 mM EDTA,
1 mM DTT and 1 mM PMSF) for 30 min and centrifuged at
15000 · g for 10 min. In a total volume of 300 ll, the reaction mixture
containing 200 ll of the cell lysate, 10 ll of Ab-bound proteinA Se-
pharose, and the lysis buﬀer containing 0.1% BSA was incubated at
4 C for overnight. After successive washings, Ab-bound proteins were
eluted in a step-wise manner with the wash buﬀer containing 0.5, 1, 2
2.5 and 3 M NaCl, respectively. The in-gel digestion with trypsin
(Sequencing grade, Promega) was performed as previously described
[16]. A MALDI-TOF MS analysis was then performed using Ultra
Flex (BRUKER DALTONICS) and Mascot search (Matrix Science
Inc.) according to the manufacturer’s instructions.
2.4. Indirect immunoﬂuorecence
The cells were ﬁxed with 4% paraformaldehyde in PBS for 10 min
and permeabilized with 0.1% NP-40 in PBS for 20 min, and then were
incubated for 1 h with anti-M1 rabbit antiserum or anti-NP rabbit
antiserum and anti-Hsc70 rat Mab. After washing with PBS, the cells
were incubated for 1 h with the secondary antibodies, Alexa546- con-
jugated anti-rabbit Ig and Alexa488-conjugated anti-rat Ig. The cells
were observed under microscopy.
2.5. Real-time PCR analysis
RNA samples from virion particles were extracted by Trizol reagent
(Invitrogen) and subjected to reverse transcription using random hex-
amer and M-MLV RT (Gibco BRL). Real-time PCR reaction was per-Fig. 1. Identiﬁcation of Hsc70 as a M1 binding protein. (A) MDCK
cells, infected with inﬂuenza virus (A/PR/8/34) were lysed and
immunoprecipitated using anti-M1. The immunoprecipitates were
successively washed, and then were eluted with 3 M NaCl, and
subjected to 10% SDS–PAGE, followed by CBB staining. The
arrowhead indicates a speciﬁc band detected only in a viral infected
sample. (B) Hsc70 spectrum by MALDI-TOF MS. The viral infection-
speciﬁc band (panel A, lane 2, arrowhead) was identiﬁed as Hsc70
(P < 0.05). (C) The puriﬁed inﬂuenza viral particles were analyzed by
10% SDS–PAGE. Typical bands were excised from the CBB-stained
gel and then were subjected to MALDI-TOF MS. The identiﬁed
proteins (P < 0.05) were shown in the ﬁgure.formed with Cepheid SmartCycler II (Cepheid, Sunnyvale, CA)
using SYBR Green I and speciﬁc primers, 5 0-TCTGATCCTCTCGT-
CATTGCAGCAA-3 0 and 5 0-AATGACCATCGTCAACATCCA-
CAGC-3 0, corresponding to nucleotide position between 782 and 984
of A/WSN/33 segment 7 viral genome. The serial dilution of pPol-
WSN-M plasmid were used to calculate the copy numbers of ampliﬁed
DNA.3. Results and discussion
3.1. Identiﬁcation of M1-binding protein
To explore the host factor(s) which interact with M1, the
combination of an immunoprecipitation and MALDI-TOF
MS was conducted (Fig. 1). The inﬂuenza virus infected
MDCK cells were lysed and immunoprecipitated with anti-
M1. The proteins binding to M1 were eluted in a step-wise
manner with the increasing NaCl concentration and then were
analyzed by SDS–PAGE. Each eluted sample contained sev-
eral speciﬁc bands (data not shown). In 3 M NaCl elute frac-
tion, a speciﬁc band (70 kDa) was obtained (Fig. 1A,
arrowhead) and identiﬁed as Hsc70 (Fig. 1B, P < 0.05). Puri-
ﬁed virion were also analyzed by MALDI-TOF MS
(Fig. 1C). In addition to viral structural proteins, host proteins
including Hsc70 were identiﬁed. This ﬁnding correlates with
those of previous studies in which Hsc70 is incorporated into
vesicular stomatitis virus, Newcastle disease virus inﬂuenza
virus and Rabies virus [17].Fig. 2. Hsc70- M1 interaction. (A) The cells were infected with the
inﬂuenza virus A/PR/8/34 (MOI = 1) for 12 h. The cell lysates were
subjected to 10% SDS–PAGE, followed by Western blotting as
indicated. (B) HeLa cells were infected with A/PR/8/34 (MOI = 1) for
12 h. The cell lysates were immunoprecipitated with anti-M1 or control
rabbit normal serum and then were visualized with anti-Hsc70 or anti-
M1 after 10% SDS–PAGE. (C) A/PR/8/34-infected cells were subjected
to immunoprecipitation using anti-Hsc70 or rat anti-mouse IgG1 Mab
as indicated. Immunoprecipitates were analyzed by 10% SDS–PAGE,
and then were visualized with anti-Hsc70 or anti-M1.
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Hsc70 is a member of Hsp70 family protein, constitutively
expressed in the cell (Fig. 2A). The inﬂuenza virus infection
did not aﬀect the expression level of Hsc70, whereas that of
Hsp70 increased both in HeLa and MDBK cells. Next, the
interaction between Hsc70 and M1 was conﬁrmed by co-
immunoprecipitation experiment using anti-M1 (Fig. 2B) or
anti-Hsc70 (Fig. 2C). Hsc70 coprecipitates with M1 in HeLa
cells (Fig. 2B, lane 4), MDBK and MDCK cells (data not
shown). Using anti-Hsc70 antibody, M1 was co-precipitated
with Hsc70 in MDBK, MDCK and HeLa cells (Fig. 2C).
3.3. C-terminal half of M1 interacts with Hsc70
Fig. 3 shows Hsc70 binding domain of M1. We mimicked
the late stage of virus infection in the cells by a genome plas-
mid expression system with human RNA-polymerase I (polI)Fig. 3. Determination of Hsc70 binding domain of M1. (A) Diagram of a ser
immunoprecipitation (B) or Far Western blotting (C). (B) Viral RNP-mediat
293T cells. M1 genome RNA is transcribed under the control of human polI
RNA forms a viral RNP complex, then M1 protein is synthesized. 293T cells
(lane 3), pPolI-WSN-MD76-103 (lane 4), pPolI-WSN-MD102–201 (lane 5), p
presence of viral polymerases and NP-expressing plasmids (lanes 3–6), res
subjected to immunoprecipitation using anti-M1 antiserum. (C) Far-western
mutants, D1–75 (lane 2), D76–115 (lane 3), D112–252 (lane 4) and D91–252 (l
membrane, then followed by denaturation with 6 M guanidine HCl in TBST
with 1 lg/ml of each puriﬁed GST-Hsc70 [23] or GST in TBST at 4 C for 4
anti-Hsc70 antibody.promoter [15] (Fig. 3B). The plasmid encoding M gene
(pPolI-WSN-M) is transcribed into a viral genome, and then
it is assembled with viral proteins, PA, PB1, PB2 and NP.
M1 protein is produced from this vRNP complex. Using dele-
tion mutants of M1, no association between M1D102–201 and
Hsc70 was observed, whereas D76–103, which lacks an RNA
binding domain, still bind to Hsc70 (Fig. 3B). It is also cleared
that M1 interacts with Hsc70 in the absence of any other viral
proteins (Fig. 3C). These results suggest that the C terminal
half of M1 interacts with Hsc70.
3.4. Localization of Hsc70 in virus infected cells
In uninfected cells, Hsc70 localizes dominantly in the cyto-
plasm at 37 C (Fig. 4a and g). In the early stages (3 h) of virus
infection, when M1 was not expressed yet (e), an early protein,
NP, localizes in the nucleus (k). The localization of Hsc70 aties of deletion mutants of M1. Hsc70-M1 interaction was conﬁrmed by
ed expression of M1 protein. Plasmids were cotransfected into human
promoter. NP, viral polymerases (PA, PB1 and PB2) and M1 genome
were transfected with pCAGGS-M1 (lane 2), pPolI-WSN-M wild type
PolI-WSN-MD204–252 (lane 6), in the absence (lanes 1 and 2) or the
pectively. Twenty-four hours after transfection, the cell lysates were
assay. E. coli-expressed crude lysate of His-M1 (lane 1) and its deletion
ane 5) [4] were separated by 13% SDS–PAGE, transferred onto PVDF
for 10 min. After stepwise renaturating, the membrane was incubated
h. Speciﬁc signals were detected by a Western blotting procedure using
Fig. 4. Localization of Hsc70, M1 and NP in inﬂuenza virus infected cells. MDCK cells infected with A/WSN/33 (MOI = 1) were ﬁxed and reacted
with anti-M1 (Alexa 546: Red) or anti-NP (Alexa 546: Red) together with anti-Hsc70 (Alexa 488: Green). The ﬂuorescent cells were observed by
confocal microscopy (LSM, Carl Zeiss).
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ever, the localization of Hsc70 changed drastically to the nu-
cleus in the late stages (9 h) of viral infection where M1 was
dominantly localized (Fig. 4c). Similar results were observed
when HeLa cells, and A/PR/8/34(H1N1) viruses were used
(data not shown).
3.5. Hsc70 requires for nuclear export of vRNP and virus
production
We investigated whether the expression level of Hsc70 aﬀects
the localization of the viral proteins and virus production
(Fig. 5). We have introduced SiRNA speciﬁc to Hsc70 and suc-
ceeded in about 90% reduction of Hsc70 in 84 h as shown in
Fig. 5A. Seventy-two hours after an SiRNA transfection, the
cells were infected with the virus at a MOI of 0.1 (5000
PFU/well). The cells were extensively washed and then were
incubated further with 500 ll of the medium. About
14000 PFU/ml (without SiRNA) or 20000 PFU/ml (with Ran-
dom SiRNA) of the virus titer at 12 h post infection was signif-
icantly reduced to 2000 PFU/ml in the Hsc70-speciﬁc SiRNAtreated sample. The data obtained at 36 h post infection
strengthen the results (Fig. 5B). It is also possible that a lack
of Hsc70 may also aﬀect the infectivity of the virus but not
the production. We therefore examined the number of virus
particles released from the cell by quantifying the RNA gen-
ome copy using a real-time PCR analysis (Fig. 5C). Our results
suggested that Hsc70 aﬀects the production of the virus but not
the infectivity. M1, NP and Hsc70 localized in nucleus at 9 hr
(see Fig. 4) were exported from nucleus and localize both nu-
cleus and cytoplasm at 24 h (Fig. 5D, a, e, h and l) where the
assembly of the virus occurs. When Hsc70 expression was sup-
pressed by the SiRNA transfection (Fig. 5D, b and i), M1 (f)
and NP (m) were accumulated in nucleus and thus failed to
be exported from the nucleus. These results clearly suggested
that Hsc70 is therefore required for the nuclear export of
vRNP-M1 complex.
3.6. Roles of Hsps in the late stages of virus infection
Our previous study and an X-ray structure analysis
showed amino acid residues 91–105 of M1 is involved in
Fig. 5. Hsc70 requires for export of vRNP and virus production. (A) HeLa cells were transfected with Hsc70 speciﬁc or control random SiRNA. The
cell lysate was recovered after either 36, 60 or 84 h, and then it was subjected to Western blotting as indicated. Seventy-two (B) or 48 h (C and D)
after SiRNA transfection, the cells were infected with A/WSN/33 at a MOI of 0.1 and further incubated. (B) The infectious viral titer in the medium
was estimated by a plaque assay. The results represent the means + S.E. The representative data of three independent experiments are indicated. (C)
The production of the virus particle was estimated by a real-time PCR analysis. The results represent the means + S.E. The representative data of
three independent experiments are indicated. (D) The cells were observed by Axiophot microscopy (LSM, Carl Zeiss).
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cinB (LMB), an inhibitor of CRM1-mediated nuclear export,
inhibits the export of vRNP [19]. However, M1 does not have
a nuclear export signal (NES). The mechanism of M1-medi-
ated vRNP export is still unclear. It is possible to speculate
the possible existence of a host factor which regulates vRNPs
export. In this communication, we clearly demonstrated that
Hsc70 directly bind to M1 at C terminal half of M1
(Fig. 3C). Hsc70-speciﬁc SiRNA treatment results in reduc-
tion of virus production (Fig. 5B and C) by the inhibitionof the nuclear export of M1 and vRNP (Fig. 5D). We recently
reported that Hsc70 possess the NES [20], thus suggesting
that Hsc70 promotes the nuclear export of M1 and vRNP.
We also found M1 to be associated with Hsp90 (data not
shown) and PA [3], while Hsp90 stimulates the inﬂuenza virus
RdRp activity [21]. Hsc70 and Hsp90 may therefore act as a
stimulating factor on various steps of the inﬂuenza virus life
cycle by the association with vRNP. On the other hand, it
was reported that Hsp70 induced at 41 C inhibited the
export of vRNP in MDCK cells [22]. Further studies are thus
5790 K. Watanabe et al. / FEBS Letters 580 (2006) 5785–5790necessary to explore the detailed mechanisms of Hsps in the
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